Live feed
Filing
SC 13D/A
SC 13D/A0000919574-19-005934·ARMISTICE CAPITAL, LLC
Schedule 13D ownership disclosure
INNOVUS PHARMACEUTICALS, INC.
Security class unavailable · CUSIP: 45778V106
Event date: 2019-09-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-19-005934
- Form type
- SC 13D/A
- Filer
- ARMISTICE CAPITAL, LLC
- CIK
- CIK 1601086
- Filed
- Sep 19, 2019
- Reporting period
- Sep 12, 2019
- Description
- Schedule 13D beneficial ownership